PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGeneStudy

Authors

Keywords

Journal

Volume 50, Issue 4, Pages 723-729

Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Online

2008-11-11

DOI

10.1194/jlr.m800414-jlr200

References

View 2 related references

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now